EXPERIMENTAL IMMUNOLOGY
Expression of surface and intracellular Toll-like receptors by mature mast cells
Submission date: 2016-07-01
Final revision date: 2016-09-19
Acceptance date: 2016-09-22
Publication date: 2017-01-24
Cent Eur J Immunol 2016;41(4):333-338
KEYWORDS
ABSTRACT
Nowadays, more and more data indicate that mast cells play an important role in host defense against pathogens. That is why it is essential to understand the expression of Toll-like receptors (TLRs) by mast cells, because these molecules play particularly significant role in initiation host defense against microorganisms as they recognize both wide range of microbial pathogen-associated molecular patterns (PAMPs) and various endogenous damage-associated molecular patterns (DAMPs) released in response to infection. Therefore, we examined the constitutive expression of both surface and endosomal TLRs in rat native fully mature tissue mast cells. By the use of qRT-PCR we found that these cells express mRNAs for TLR2, TLR3, TLR4, TLR5, TLR7, and TLR9. The expression of TLR3, TLR4, TLR5, TLR7, and TLR9 transcripts were low and comparable and only the expression of TLR2 transcript was significant. By the use of flow cytometry technique, we clearly documented that mast cells express TLR2, TLR4, and TLR5 on cell surface, while TLR3, TLR7, and TLR9 proteins are located both on the cell membrane and intracellularly. The highest expression was observed for TLR5 and the lowest for surface TLR7. These observations undoubtedly indicate that mature tissue mast cells have a broad set of TLR molecules, thus can recognize and bind bacterial, viral, and fungal PAMPs as well as various endogenous molecules generated in response to infection.
REFERENCES (42)
1.
Wernersson S, Pejler G (2014): Mast cell secretory granules: armed for battle. Nat Rev Immunol 14: 478-494.
2.
Krystel-Whittemore M, Dileepan KN, Wood JG (2016): Mast cell: a multi-functional master cell. Front Immunol 6: 620.
3.
da Silva EZ, Jamur MC, Oliver C (2014): Mast cell function: a new vision of an old cell. J Histochem Cytochem 62: 698-738.
4.
Metz M, Grimbaldeston MA, Nakae S, et al. (2007): Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217: 304-328.
5.
Theoharides TC, Alysandratos KD, Angelidou A, et al. (2012): Mast cells and inflammation. Biochim Biophys Acta 1822: 21-33.
6.
Shelburne CP, Abraham SN (2011): The mast cell in innate and adaptive immunity. Adv Exp Med Biol 716: 162-185.
7.
Modena BD, Dazy K, White AA (2016): Emerging concepts: mast cell involvement in allergic diseases. Transl Res 174: 98-121.
8.
Trivedi NH, Guentzel MN, Rodriguez AR, et al. (2013): Mast cells: multitalented facilitators of protection against bacterial pathogens. Expert Rev Clin Immunol 9: 129-138.
9.
Witczak P, Brzezińska-Błaszczyk E (2012): Mast cells in viral infections. Postepy Hig Med Dosw 66: 231-244.
10.
Di Nardo A, Vitiello A, Gallo RL (2003): Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170: 2274-2278.
11.
Malaviya R, Twesten NJ, Ross EA, et al. (1996): Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156: 1490-1496.
12.
Malaviya R, Ross EA, MacGregor JI, et al. (1994): Mast cell phagocytosis of FimH-expressing enterobacteria. J Immunol 152: 1907-1914.
13.
von Köckritz-Blickwede M, Goldmann O, Thulin P, et al. (2008): Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111: 3070-3080.
14.
Dimitriadou V, Mécheri S, Koutsilieris M, et al. (1998): Expression of functional major histocompatibility complex class II molecules on HMC-1 human mast cells. J Leukoc Biol 64: 791-799.
15.
Kumagai Y, Takeuchi O, Akira S (2008): Pathogen recognition by innate receptors. J Infect Chemother 14: 86-92.
16.
Takeuchi O, Akira S (2010): Pattern recognition receptors and inflammation. Cell 140: 805-820.
17.
Yamamoto M, Takeda K (2010): Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010: 240365.
19.
Kawasaki T, Kawai T (2014): Toll-like receptor signaling pathways. Front Immunol 5: 461.
20.
Pietrzak A, Wierzbicki M, Wiktorska M, Brzezińska-Błaszczyk E (2011): Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm 2011: 427473.
21.
Yoshioka M, Fukuishi N, Iriguchi S, et al. (2007): Lipoteichoic acid downregulates FcRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 120: 452-461.
22.
McCurdy JD, Olynych TJ, Maher LH, Marshall JS (2003): Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170: 1625-1629.
23.
Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD (2004): Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114: 174-182.
24.
Kubo Y, Fukuishi N, Yoshioka M, et al. (2007): Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflamm Res 56: 70-75.
25.
McCurdy JD, Lin TJ, Marshall JS (2001): Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70: 977-984.
26.
Inomata N, Tomita H, Ikezawa Z, Saito H (2005): Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells. Immunol Lett 98: 265-271.
27.
Sundstrom JB, Little DM, Villinger F, et al. (2004): Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol 172: 4391-4401.
28.
Varadaradjalou S, Féger F, Thieblemont N, et al. (2003): Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33: 899-906.
29.
Ikeda T, Funaba M (2003): Altered function of murine mast cells in response to lipopolysaccharide and peptidoglycan. Immunol Lett 88: 21-26.
30.
Matsushima H, Yamada N, Matsue H, Shimada S (2004): TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 173: 531-541.
31.
Mrabet-Dahbi S, Metz M, Dudeck A, et al. (2009): Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp Dermatol 18: 437-444.
32.
Stassen M, Müller C, Arnold M, et al. (2001): IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-B is decisively involved in the expression of IL-9. J Immunol 166: 4391-4398.
33.
Supajatura V, Ushio H, Nakao A, et al. (2001): Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167: 2250-2256.
34.
Yang H, Wei J, Zhang H, et al. (2009): Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF. BMC Cell Biol 10: 37.
35.
Orinska Z, Bulanova E, Budagian V, et al. (2005): TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106: 978-987.
36.
Kulka M, Metcalfe DD (2006): TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 43: 1579-1586.
37.
Yoshioka M, Fukuishi N, Kubo Y, et al. (2008): Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm Bull 31: 212-226.
38.
Feng BS, He SH, Zheng PY, et al. (2007): Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am J Pathol 171: 537-547.
39.
Konopka Ł, Wierzbicki M, Brzezińska-Błaszczyk E (2010): Lipopolysaccharide from Porphyromonas gingivalis stimulates rat mast cells to cysteinyl leukotriene generation and upregulates Toll-like receptor-2 and -4 expression. Int J Immunopathol Pharmacol 23: 803-810.
40.
Witczak P, Pietrzak A, Wódz K, Brzezińska-Błaszczyk E (2014): Mast cells generate cysteinyl leukotrienes and interferon-beta as well as evince impaired IgE-dependent degranulation upon TLR7 engagement. Indian J Exp Biol 52: 589-596.
41.
Witczak P, Pietrzak A, Słodka A, Brzezińska-Błaszczyk E (2013): Toll-like receptors 3 ligation directly and indirectly affects mast cell cysteinyl leukotriene generation. Cent Eur J Immunol 38: 343-348.
42.
Passante E, Ehrhardt C, Sheridan H, Frankish N (2009): RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm Res 58: 611-618.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
